Rhenix Lifesciences is a 2021-founded R&D organization in the Health Care industry, aiming to personalize science. The company's core focus lies in leveraging bioinformatics and digital medicine to facilitate scientific advancement. By harnessing technologies like Artificial Intelligence (AI) and IoT, Rhenix Lifesciences seeks to identify innovative pathways for therapeutic opportunities across various diseases. Moreover, the company provides support to scientific organizations through services such as protocol writing, scientific consulting, and digital transformation. With a team of multidisciplinary scientists, Rhenix Lifesciences aspires to enhance scientific access and research capabilities. Despite the absence of disclosed headquarters or last investment details, the company's commitment to advancing scientific accessibility and innovation positions it as a potential candidate for research-focused investments in the life sciences sector.
There is no investment information
No recent news or press coverage available for Rhenix Lifesciences.